Award notice · Contracts Finder
project_35333 - Antigen Mining for Diagnostically Relevant Serum
Part of project_35333 - Antigen Mining for Diagnostically Relevant Serum.
ADI has expressed encoded recombinant proteins by in vitro transcription/translation (IVTT) reactions of 4,081 clones representing 3,873 strain H37RV proteins (99% of genome) and printed them onto custom nitrocellulose-coated microarray slides after construction of Mtb expression plasmids by PCR/recombination cloning. The microarray slides will be validated and checked for quality by probing with a monoclonal antibody recognizing the N-terminal poly-Histidine tag and C-terminal HA tag.
- Published
- 1 Apr 2022
- Status
- complete
- CPV
- 73000000 — Research and development services and related consultancy services
- Tender period
- — – 17 Mar 2022
Awards
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award notice published via Contracts Finder on 1 Apr 2022.
Which procurement does this notice belong to?
It is part of "project_35333 - Antigen Mining for Diagnostically Relevant Serum", published by Defra Network eTendering Portal.
Has this notice resulted in an award?
1 award is recorded on this notice, including to Antigen Discovery Inc.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable